Literature DB >> 15201012

Treatment of acute heart failure in an infant after cardiac surgery using levosimendan.

Jan-Peter Braun1, Martin Schneider, Marc Kastrup, Jianshi Liu.   

Abstract

An infant, 2 months old, underwent cardiac surgery because of congenital heart defects and pulmonary hypertension. Surgery was performed in hypothermia and cardiac standstill. On the second day after surgery the infant had to be resuscitated due to a combination of acute left-ventricular failure, pulmonary vascular hypertension and a slight right-to-left-shunt. A breakthrough in the treatment was achieved by using levosimendan to improve left-ventricular function and to decrease vascular resistance.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15201012     DOI: 10.1016/j.ejcts.2004.03.034

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  10 in total

Review 1.  Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease.

Authors:  Johanna Hummel; Gerta Rücker; Brigitte Stiller
Journal:  Cochrane Database Syst Rev       Date:  2017-08-02

2.  First experiences with intraoperative Levosimendan in pediatric cardiac surgery.

Authors:  Wilhelm Alexander Osthaus; Dietmar Boethig; Michael Winterhalter; Dirk Huber; Heidi Goerler; Michael Sasse; Robert Sümpelmann
Journal:  Eur J Pediatr       Date:  2008-09-24       Impact factor: 3.183

Review 3.  Future pharmacologic agents for treatment of heart failure in children.

Authors:  Brady S Moffett; Anthony C Chang
Journal:  Pediatr Cardiol       Date:  2006-08-23       Impact factor: 1.655

Review 4.  Is levosimendan effective in paediatric heart failure and post-cardiac surgeries?

Authors:  Ullas Angadi; Claire Westrope; Mohammed F Chowdhry
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-07-06

Review 5.  [Role of Levosimendan in intensive care treatment of myocardial insufficiency].

Authors:  S Rehberg; C Ertmer; H Van Aken; M Lange; K Bröking; A Morelli; M Westphal
Journal:  Anaesthesist       Date:  2007-01       Impact factor: 1.041

6.  Use of Levosimendan in Postoperative Setting After Surgical Repair of Congenital Heart Disease in Children.

Authors:  Vivianne Amiet; Marie-Hélène Perez; David Longchamp; Tatiana Boulos Ksontini; Julia Natterer; Sonia Plaza Wuthrich; Jacques Cotting; Stefano Di Bernardo
Journal:  Pediatr Cardiol       Date:  2017-09-07       Impact factor: 1.655

7.  Single-center experience with levosimendan in children undergoing cardiac surgery and in children with decompensated heart failure.

Authors:  Pertti K Suominen
Journal:  BMC Anesthesiol       Date:  2011-10-05       Impact factor: 2.217

8.  Milrinone is preferred to levosimendan for mesenteric perfusion in hypoxia-reoxygenated newborn piglets treated with dopamine.

Authors:  Namdar Manouchehri; David L Bigam; Thomas Churchill; Chloe Joynt; Maximo Vento; Po-Yin Cheung
Journal:  Pediatr Res       Date:  2012-01-11       Impact factor: 3.756

9.  Levosimendan in pulmonary hypertension and right heart failure.

Authors:  Mona Sahlholdt Hansen; Asger Andersen; Jens Erik Nielsen-Kudsk
Journal:  Pulm Circ       Date:  2018-07-06       Impact factor: 3.017

Review 10.  Physiological Changes in Subjects Exposed to Accidental Hypothermia: An Update.

Authors:  Lars J Bjertnæs; Torvind O Næsheim; Eirik Reierth; Evgeny V Suborov; Mikhail Y Kirov; Konstantin M Lebedinskii; Torkjel Tveita
Journal:  Front Med (Lausanne)       Date:  2022-02-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.